The American Cancer Society (ACS) 2024 report emphasizes significant racial disparities in breast cancer outcomes and calls ...

Speakers at the 2024 International Myeloma Society (IMS) conference share the updates from the myeloma space that they were ...

Finerenone showed consistent cardiovascular benefits across heart failure populations, with enhanced efficacy in patients ...

CVS Health is set to lay off 2900 employees nationwide, primarily in corporate roles, as part of a $2 billion cost-saving ...

April Armstrong, MD, MPH, chief of dermatology, UCLA, discusses the impact of a new oral therapy option for patients with ...

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative ...

Investigators from Florida Cancer Specialists & Research Institute explored questions surrounding minimal residual disease ...

Ajai Chari, MD, covered both recent FDA approvals and pipeline products, such as non-BCMA chimeric antigen receptor (CAR) ...

The 2024 Trends Shaping the Health Economy report gave a past, present, and future look at diabetes care in the US and the ...

Over the past decade we’ve seen rapid growth in value-based care programs. While some have succeeded in improving quality or ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses improvements in lung function observed in patients enrolled in the BOREAS trial.

Javed Butler, MD, MPH, MBA, discusses the additional benefits of combining finerenone with sodium-glucose cotransporter-2 ...